Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant MuLV Nucleocapsid protein p10-gag/NC-gag Protein, N-His

Catalog #:   YVV44004 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P03336
Protein length: Ala478-Asp537
Overview

Catalog No.

YVV44004

Expression system

E. coli

Species

AKV murine leukemia virus (AKR (endogenous) murine leukemia virus)

Protein length

Ala478-Asp537

Predicted molecular weight

8.82 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P03336

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Gag polyprotein, Capsid protein, gag, Core polyprotein, Nucleocapsid protein p10-gag, NC-gag

Data Image
References

A Novel Thermostable and Processive Reverse Transcriptase from a Group II Intron of Anoxybacillus flavithermus., PMID:38254649

Polypyridyl ruthenium complexes as bifunctional TAR RNA binders and HIV-1 reverse transcriptase inhibitors., PMID:35679745

RNA Structural Requirements for Nucleocapsid Protein-Mediated Extended Dimer Formation., PMID:35337013

Physiological magnesium concentrations increase fidelity of diverse reverse transcriptases from HIV-1, HIV-2, and foamy virus, but not MuLV or AMV., PMID:34904939

The attachment of a DNA-binding Sso7d-like protein improves processivity and resistance to inhibitors of M-MuLV reverse transcriptase., PMID:32970841

Mouse APOBEC3 interferes with autocatalytic cleavage of murine leukemia virus Pr180gag-pol precursor and inhibits Pr65gag processing., PMID:31830125

Decreased Km to dNTPs is an essential M-MuLV reverse transcriptase adoption required to perform efficient cDNA synthesis in One-Step RT-PCR assay., PMID:29608777

Interference of retroviral envelope with vaccine-induced CD8+ T cell responses is relieved by co-administration of cytokine-encoding vectors., PMID:28449719

Synthesis of Pyridone-based Nucleoside Analogues as Substrates or Inhibitors of DNA Polymerases., PMID:26854871

Selective binding and reverse transcription inhibition of single-strand poly(A) RNA by metal TMPyP complexes., PMID:25203754

Gammaretrovirus mRNA expression is mediated by a novel, bipartite post-transcriptional regulatory element., PMID:25190459

Modulation of stop codon read-through efficiency and its effect on the replication of murine leukemia virus., PMID:24991001

Human immunodeficiency virus reverse transcriptase displays dramatically higher fidelity under physiological magnesium conditions in vitro., PMID:24850729

Development of an enzyme-linked immunosorbent assay based on the murine leukemia virus p30 capsid protein., PMID:23810854

Compartmentalization of destabilized enzyme-mRNA-ribosome complexes generated by ribosome display: a novel tool for the directed evolution of enzymes., PMID:23667164

Viral DNA tethering domains complement replication-defective mutations in the p12 protein of MuLV Gag., PMID:23661057

MoMuLV and HIV-1 nucleocapsid proteins have a common role in genomic RNA packaging but different in late reverse transcription., PMID:23236513

Viral reverse transcriptases show selective high affinity binding to DNA-DNA primer-templates that resemble the polypurine tract., PMID:22848574

Moloney murine leukemia virus glyco-gag facilitates xenotropic murine leukemia virus-related virus replication through human APOBEC3-independent mechanisms., PMID:22828015

Generation and characterization of new highly thermostable and processive M-MuLV reverse transcriptase variants., PMID:22691702

Functional mechanisms of the cellular prion protein (PrP(C)) associated anti-HIV-1 properties., PMID:22076653

Selective inactivation of M-MuLV RT RNase H activity by site-directed PEGylation: an improved ability to synthesize long cDNA molecules., PMID:21807127

The cellular protein La functions in enhancement of virus release through lipid rafts facilitated by murine leukemia virus glycosylated Gag., PMID:21343359

Fluoride-cleavable, fluorescently labelled reversible terminators: synthesis and use in primer extension., PMID:21294195

The glycosylated Gag protein of a murine leukemia virus inhibits the antiretroviral function of APOBEC3., PMID:20702647

Mass spectrometry of murine leukemia virus core proteins., PMID:20691207

Biochemical characterization of enzyme fidelity of influenza A virus RNA polymerase complex., PMID:20454455

Multiple nucleotide preferences determine cleavage-site recognition by the HIV-1 and M-MuLV RNases H., PMID:20122939

Inactivation of respiratory syncytial virus by zinc finger reactive compounds., PMID:20102602

Murine leukemia virus glycosylated Gag (gPr80gag) facilitates interferon-sensitive virus release through lipid rafts., PMID:20080538

Targeting of murine leukemia virus gag to the plasma membrane is mediated by PI(4,5)P2/PS and a polybasic region in the matrix., PMID:19828619

Influence of the RNase H domain of retroviral reverse transcriptases on the metal specificity and substrate selection of their polymerase domains., PMID:19814799

Neutralizing activity and cellular immune responses induced in mice after immunization with apoptotic HIV-1/murine leukemia virus infected cells., PMID:19549607

Physiological properties of astroglial cell lines derived from mice with high (SAMP8) and low (SAMR1, ICR) levels of endogenous retrovirus., PMID:19032740

Inability of human immunodeficiency virus type 1 produced in murine cells to selectively incorporate primer formula., PMID:18842718

Deoxynucleoside triphosphate incorporation mechanism of foamy virus (FV) reverse transcriptase: implications for cell tropism of FV., PMID:18508890

Quantification of reverse transcriptase in ALS and elimination of a novel retroviral candidate., PMID:18209202

Candidate HIV-1 gp140DeltaV2, Gag and Tat vaccines protect against experimental HIV-1/MuLV challenge., PMID:17707956

Viral insertion in Evi12 causes expression of aberrant Grp94 mRNAs containing the viral gag myristylation motif., PMID:17543366

Substitution of alanine for tyrosine-64 in the fingers subdomain of M-MuLV reverse transcriptase impairs strand displacement synthesis and blocks viral replication in vivo., PMID:17532359

tRNA isoacceptor preference prior to retrovirus Gag-Pol junction links primer selection and viral translation., PMID:17301132

Mutation in the glycosylated gag protein of murine leukemia virus results in reduced in vivo infectivity and a novel defect in viral budding or release., PMID:17267509

Consideration of the three-dimensional structure of core shells (capsids) in spherical retroviruses., PMID:17223564

Molecular and phylogenetic analyses of a new amphotropic murine leukemia virus (MuLV-1313)., PMID:17147829

Characterization of a nucleocapsid-like region and of two distinct primer tRNALys,2 binding sites in the endogenous retrovirus Gypsy., PMID:17040893

Retrovirus infection strongly enhances scrapie infectivity release in cell culture., PMID:16724107

Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH., PMID:16359234

A large number of T lymphocytes recognize Moloney-murine leukemia virus-induced antigens, but a few mediate long-lasting tumor immunosurveillance., PMID:15843538

Comparison of DNA polymerase activities between recombinant feline immunodeficiency and leukemia virus reverse transcriptases., PMID:15823610

Analysis of interactions of DNA polymerase beta and reverse transcriptases of human immunodeficiency and mouse leukemia viruses with dNTP analogs containing a modified sugar residue., PMID:15701045

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant MuLV Nucleocapsid protein p10-gag/NC-gag Protein, N-His [YVV44004]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only